Hydroxychloroquine Sulfate

This page contains recent news articles, when available, and an overview of Hydroxychloroquine Sulfate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

… Labs secures FDA nod to market Hydroxychloroquine Sulfate in the US  -  Jun 19, 2007
MUMBAI (Thomson Financial) - Ipca Laboratories Ltd said it has secured US Food and Drug Administration approval to market its disease modifying ... Forbes

Zydus Cadila receives USFDA approval for Hydroxychloroquine Sulfate …  -  Sep 25, 2007
The sales of Hydroxychloroquine Sulfate Tablets in the US market in 2006 as per NDC Health was estimated at USD $ 30 mn. The Company will market the drug ... Equity Bulls

Acromegaly diagnosed in a young woman presenting with headache and …  -  Dec 19, 2005
She was given 400 mg hydroxychloroquine sulfate daily for presumed severe rheumatoid arthritis, but there had been no improvement in joint symptoms. ... Nature.com

Drug/Medical Device Report Aspreva Pharmaceuticals Corporation ( …  -  Jan 12, 2008
...(Mycophenolate Mofetil). -. Teva Pharmaceutical Industries Ltd (ADR) (TEVA) /. Hydroxychloroquine Sulfate. -. Mylan Inc. (MYL) / Hydroxychloroquine Sulfate ... $70.00 - Revere Reports - Revere

Competitors by Product Report  -  Jan 12, 2008
Novartis AG (ADR) (NVS) Products:. Sandoz Hydroxychloroquine Sulfate ... Hydroxychloroquine Sulfate. Research/Preclinical Stage Products ... $75.00 - Revere Reports - Revere

Chemoprophylaxis and the epidemiological characteristics of re- …  -  Oct 1, 2006
Chemoprophylaxis with hydroxychloroquine sulfate (400 mg, once per week) is started in early summer and continued throughout the transmission season. ... Free with registration - Bulletin of the World Health Organizatio... - AccessMyLibrary.com

Ranbaxy Q2 global sales at $395mn, up 25%  -  Jul 19, 2007
With its strategy of alliances and partnerships gathering momentum, Ranbaxy will be introducing Hydroxychloroquine Sulfate Tablets USP - 200 mg under its ... Business Standard

Primary prevention of systemic lupus erythematosus  -  Jun 10, 2008
...(2007) Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus 16: 401–409 | Article | PubMed | ChemPort ... Nature.com

Article: Is hydroxychloroquine safe during pregnancy?(Rx) - Internal ...  -  Feb 15, 2005
Ophthalmology Times; April 1, 2005 ; 700+ words ... ... therapy with hydroxychloroquine sulfate (HCQ) 400 mg per day (Plaquenil Sulfate ... for follow-up? ... Pay-Per-View - Internal Medicine News - HighBeam Research

Generics makers keep new products coming.(RX/GENERICS)(Statistical …  -  Sep 17, 2007
Sandoz Glyburide-Metformin HCl $31249271.52 Teva USA Benazepril HCl $31127774.18 Sandoz Hydroxychloroquine Sulfate $30985193.80 Sandoz Methylphenidate ... Free with registration - Chain Drug Review - AccessMyLibrary.com

Travel to Malaria-Endemic Areas Requires a Mosquito Map  -  Nov 8, 2006
Aralen or Plaquenil (hydroxychloroquine sulfate) has been used continuously for years by travelers but can cause retinal toxicity after five to six years of ... MedPage Today

Article: Hydroxychloroquine 'probably safe' in pregnancy.(Obstetrics)...  -  Feb 1, 2005
Ophthalmology Times; April 1, 2005 ; 700+ words ... ... therapy with hydroxychloroquine sulfate (HCQ) 400 mg per day (Plaquenil Sulfate ... for follow-up? ... Pay-Per-View - OB GYN News - HighBeam Research

After 40 years waiting, glimmer of light at end of tunnel for SLE...  -  Sep 15, 2006
..."Anti-malarial drugs are commonly used, particularly Plaquenil (hydroxychloroquine sulfate), which is marketed by Sanofi-Aventis." ... Free with registration - M2 Presswire - AccessMyLibrary.com

Treatment of Refractory Chronic Urticaria With Sirolimus  -  Jun 24, 2008
She initially responded to combination hydroxychloroquine sulfate and colchicine, but there was suspicion that the remission was spontaneous due to her ... Archives of Dermatology

Eosinophilic Cellulitislike Reaction to Subcutaneous Etanercept...  -  Nov 4, 2005
After 5 months of therapy with prednisone, methotrexate, and hydroxychloroquine sulfate, the patient still had active arthritis, and adalimumab, ... Archives of Dermatology

After 40 years waiting, glimmer of light at the end of the tunnel for...  -  Sep 25, 2006
..."Anti-malarial drugs are commonly used, particularly Plaquenil (hydroxychloroquine sulfate), which is marketed by the French drug major Sanofi-Aventis." ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones

BRIEFING - ASIA HEALTH - SEPT 26, 2007.  -  Sep 26, 2007
The company has received an approval from the USFDA for the new Disease Modifying Anti-Rheumatic Drug (DMARD) Hydroxychloroquine Sulfate tablets in the ... $4.95 - AsiaPulse News - ECNext

After 40 years waiting, glimmer of light at the end of the tunnel for...  -  Oct 2, 2006
..."Anti-malarial drugs are commonly used, particularly Plaquenil (hydroxychloroquine sulfate), which is marketed by the French drug major Sanofi-Aventis." ... $4.95 - Pharma Marketletter - ECNext

Ophthalmology; Study findings from University of Otago provide new …  -  Jan 9, 2007
...and ocular and systemic adverse effects of patients taking hydroxychloroquine sulfate who attended an ophthalmic screening program. Retrospective study. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

New York Codes, Rules and Regulations - 9 NYCRR 4120.2. Restricted …  -  May 18, 2007
Ketoprofen (eg, Orudis); (15) orgotein (eg, Palosein); (16) hydroxychloroquine sulfate (eg, Rheaform); (17) sarapin; (18) sulfonamide drugs (eg, Sulfa); ... Pay-Per-View - New York Codes, Rules and Regulations - Loislaw

התרופות לטיפול בלופוס עורי  -  Jan 24, 2008
...פלקווניל (Hydroxychloroquine Sulfate), ×”×™×? תרופה המשמשת במקור לטיפול במלריה, וכמו תרופות רבות ... InfoMed





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy